Skip to main content

diclofenac

Generic: DICLOFENAC POTASSIUM·Brand: Aleve Arthritis Pain, Arthrotec, CAMBIA, CATAFLAM, Cambia, Cataflam, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM, DYLOJECT, Flector, Licart, Lofena, PENNSAID, Pennsaid, SOLARAZE, Solaraze, Surpass Anti-Inflammatory, Trifena, VOLTAREN, VOLTAREN ARTHRITIS PAIN, VOLTAREN-XR, Voltaren, Xiclo, ZIPSOR, ZORVOLEX, Zipsor, Zorvolex

diclofenac: developed by 1 company · 2 clinical trials tracked · 1 FDA decision.

diclofenac evidence translation

What we can confirm

1 FDA record · 2 tracked trials

What it means

Source-backed records connect diclofenac to ZCOR; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could diclofenac → ZCOR affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 2 study sponsors

Related indications

mild to moderate acute pain and osteoarthritis painChronic PainPain
Development Pipeline (1)
CompanyPhase
Zyla Life Sciences (ZCOR)
mild to moderate acute pain and osteoarthritis pain
Approved
Clinical Trials (2)

A Randomized Controlled Trial: Alternative Post Procedural Analgesia With NSAIDs vs Opioids in Percutaneous Needle Tenotomy of Elbow

NCT06373978·Phase 4·ASRT
Recruiting

Primary endpoint: Number of pills taken

InterventionalRandomizedquadruple92 targetStarted 2024-08Completion 2026-062 sites · United StatesThe Cleveland Clinic

A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet®) vs. Diclofenac (Voltaren®) in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)

NCT00766402·Phase 4·JNJ
Terminated

Primary endpoint: Change From Baseline in Visual Analogue Scale (VAS) Score at Week 2

InterventionalRandomizedopen8 targetStarted 2008-09Completion 2009-031 site · TaiwanJohnson & Johnson Taiwan Ltd
FDA Decisions1 records
NDA204592Type 3 - New Dosage FormStandardOralCapsule

Frequently asked questions

Who is developing diclofenac?

diclofenac is being developed by Zyla Life Sciences.

How many clinical trials involve diclofenac?

BioSniper tracks 2 clinical trials involving diclofenac.

What is diclofenac's latest FDA decision?

The most recent tracked FDA decision for diclofenac is Approval, dated October 18, 2013.